Projected 2020 revenue for top drugs approved in U.S. 2015

Projected 2020 revenue for top drugs approved in the U.S. in 2015 (in billion U.S. dollars)

by Statista Research Department, last edited Mar 30, 2016
Projected 2020 revenue for top drugs approved in U.S. 2015 This statistic displays the projected 2020 revenue for top drugs approved in the U.S. in 2015. Entresto, approved on July 7, 2015, and developed by Swiss company Novartis, is estimated to generate 2.48 billion U.S. dollars of revenue in 2020.
Show more

Projected 2020 revenue for top drugs approved in the U.S. in 2015 (in billion U.S. dollars)

You need to log in to download this statistic
Register for free
Already a member?
Log in
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Pharmaceutical industry in Norway "
  • Overview
The most important statistics
  • Production and trade
  • Pharmaceutical turnover
  • R&D, patents and new products
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: You might find this interesting as well
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.